Nephrology & urology
Kidney & urinary clinical trials
Kidney disease and conditions of the bladder and urinary tract. We’re tracking 4,386 recruiting studies in this area right now.
By phase
- Not applicable2,716
- Phase 2569
- Phase 1363
- Phase 3265
- Phase 1/Phase 2227
- Phase 4191
- Phase 2/Phase 355
Top conditions
- Prostate Cancer644
- Bladder Cancer186
- Acute Kidney Injury134
- Chronic Kidney Diseases122
- Chronic Kidney Disease107
- Breast Cancer104
- Renal Cell Carcinoma80
- Urinary Incontinence60
- Kidney Cancer59
- Colorectal Cancer57
- Ovarian Cancer56
- Lung Cancer51
- Cancer48
- Lupus Nephritis48
- Melanoma47
- Head and Neck Cancer46
- Metastatic Prostate Cancer46
- Hypertension45
Leading sponsors
- Mayo Clinic64
- National Cancer Institute (NCI)48
- Peking University First Hospital39
- M.D. Anderson Cancer Center36
- Chinese University of Hong Kong33
- Novartis Pharmaceuticals33
- IRCCS Azienda Ospedaliero-Universitaria di Bologna29
- Memorial Sloan Kettering Cancer Center29
- AstraZeneca28
- Assistance Publique - Hôpitaux de Paris27
Where studies are running
- California356
- Arizona109
- Alabama107
- New York96
- Florida93
- Maryland91
- Texas91
- Massachusetts88
- Illinois66
- Minnesota50
Recruiting studies4,386 total
- NCT07088536Recruiting
Returning to work after urology surgery
This study looks at how urology surgeries, like removing a kidney or treating kidney stones, affect patients' ability to return to work. It will help doctors understand the challenges patients face when going back to their jobs.
Krakow, MalopolskaAges 18 years+ - NCT07093866RecruitingPhase 2
Targeted drug combo for advanced prostate cancer
This trial tests a combination of two drugs—disitamab vedotin (a targeted antibody-drug that attacks HER2-positive cancer cells) and abiraterone (a hormone therapy)—to see if they can slow or shrink prostate cancer that has spread and become resistant to standard treatments.
Nanjing, JiangsuAges 18–75 - NCT07093177Recruiting
Telehealth exercise program for rural men with advanced prostate cancer
This trial tests a telehealth exercise program for men with advanced prostate cancer who live in rural areas. It aims to improve health and quality of life through supervised exercise sessions at home.
Salt Lake City, UtahAges 18 years+ - NCT07091565Enrolling by invitation
Sexual recovery after bladder removal for women
This study explores how bladder cancer and bladder removal surgery affect your sex life and sexual recovery. By sharing your experience in a private interview, you can help doctors and nurses better support other women undergoing similar treatments.
LondonAges 18 years+ - NCT07087860RecruitingPhase 2
Plasma exchange plus targeted therapy for advanced bladder cancer
This trial tests a procedure called therapeutic plasma exchange (TPE) combined with the drugs enfortumab vedotin and pembrolizumab for people with advanced bladder cancer that has stopped responding to standard treatments. The goal is to see if TPE helps the drugs work better.
Rochester, MinnesotaAges 18 years+ - NCT07089550Recruiting
PSMA PET scans to track treatment response in advanced prostate cancer
This study uses a special type of scan called a PSMA PET to see how well different prostate cancer treatments are working. It is for people with advanced prostate cancer who are about to start or change systemic therapy.
Bologna, ItalyAges 18 years+ - NCT07093749Recruiting
Antibiotics and symptom tracking in children
This study looks at how children with common infections feel while taking antibiotics. The goal is to better understand symptom patterns during treatment.
Melbourne, VictoriaAges 4–17 - NCT07092566RecruitingPhase 3
Pain relief after robotic kidney surgery: R.E.C.K. vs Exparel
This trial tests two different pain-relief medicines (R.E.C.K. and Exparel) given during robotic kidney surgery. It aims to find which works better to control pain after the operation.
Charlotte, North CarolinaAges 18 years+ - NCT07088198Recruiting
New surgery for nearly closed bulbar urethra stricture
This trial tests a new surgical method to repair a nearly closed bulbar urethral stricture (a narrowed part of the urine tube in the penis). This special technique uses tissue from the inside of your cheek to widen the tight spot.
Tanta, El-GharbiaAges 18 years+ - NCT06972628RecruitingPhase 2
177Lu-PSMA-617 for advanced prostate cancer with bone spread
This trial tests a radioactive drug called 177Lu-PSMA-617 to see if it can help men with metastatic castration-resistant prostate cancer that has spread to the bones in a specific pattern (superscan). It's for patients who have already tried hormone therapy and have PSMA-positive tumors.
Houston, TexasAges 18 years+ - NCT06511349RecruitingEarly Phase 1
YOLT-203 for type 1 primary hyperoxaluria (PH1)
This trial tests an experimental drug called YOLT-203 for people with type 1 primary hyperoxaluria (PH1), a rare condition that causes high oxalate levels and can damage the kidneys. It aims to see if YOLT-203 can safely help manage the disease.
Shanghai, Shanghai MunicipalityAges 2 years+ - NCT06863194RecruitingPhase 1/Phase 2
Probiotics and kidney disease progression trial
This trial tests whether taking a probiotic supplement can slow down the decline of kidney function in people with moderate chronic kidney disease (CKD stages 3 and 4). If you have stable kidney disease and are not already taking probiotics, joining this study could help researchers find a new way to protect your kidneys.
Al Mansurah, DakahliyaAges 18 years+ - NCT06852859Recruiting
Pain and symptom relief after prostate surgery
This study tracks your pain and other symptoms for three months after surgery for an enlarged prostate. The goal is to learn how well pain relief works during recovery, so doctors can improve care.
AlingsåsAges 50 years+ - NCT07082023Recruiting
Comparing two surgical methods for pelvic organ prolapse
This trial compares two minimally-invasive surgical techniques to fix pelvic organ prolapse. It aims to see which method works better and has fewer side effects.
IstanbulAges 18–75 - NCT07080840Enrolling by invitation
Phosphorus education and medication help for dialysis patients
This trial tests a program to help hemodialysis patients better understand phosphorus control and stick to their phosphate-binding medications. It aims to improve health outcomes by supporting patients who have been on dialysis for over a year.
TaichungAges Any age - NCT07082920RecruitingPhase 1
Combination treatment for advanced prostate cancer
This study tests a combination of two new investigational drugs for men with advanced prostate cancer that has spread and is no longer responding to hormone therapy. The drugs aim to help your immune system fight the cancer cells.
Sarasota, FloridaAges 18 years+ - NCT07085104RecruitingPhase 1
Study of ALLO-329 for lupus, myositis, or scleroderma
This trial tests a new one-time cell therapy (ALLO-329) made from donor cells to target and calm overactive immune cells in people with lupus, myositis, or scleroderma that hasn't improved with usual medications. It aims to see if this treatment is safe and can help reduce disease activity.
Phoenix, ArizonaAges 18–74 - NCT06975995Recruiting
Postbiotics for elderly dialysis patients
This trial tests whether postbiotics (helpful substances made by good bacteria) can reduce complications in elderly patients on hemodialysis. If you are 65 or older and have been on dialysis for at least 6 months, this study may help improve your treatment.
Beijing, Beijing MunicipalityAges 65 years+ - NCT07077239Recruiting
Adaptive radiation after prostate surgery to lower side effects
This trial tests a precise, short-course radiation treatment (stereotactic body radiotherapy) after prostate removal surgery that adapts to your body each day to reduce side effects. It is for people whose prostate cancer has high-risk features or a rising PSA after surgery.
Los Angeles, CaliforniaAges 18 years+ - NCT07076589Recruiting
New tool vs. standard tool for kidney stone surgery
This trial tests a new flexible suction tube for kidney stone removal versus the standard tube. It aims to see if the new tool works better and is safer for patients with small kidney stones.
CairoAges 14 years+ - NCT07077161RecruitingPhase 2
Skipping Cabozantinib Doses Instead of Reducing Them
This trial tests whether skipping a dose of cabozantinib instead of lowering the dose can help manage side effects while still controlling your kidney cancer. It is for people already taking cabozantinib who might need a break but want to stay on treatment.
Leiden, South HollandAges 18 years+ - NCT07081126Recruiting
Daratumumab for late antibody-mediated rejection in kidney transplant
This trial tests whether daratumumab can help treat a type of rejection that happens more than a year after a kidney transplant. It may be an option for people who have biopsy-proven antibody-mediated rejection and new donor-specific antibodies.
MartinAges 18 years+ - NCT07075900Recruiting
Comparing two exercise programs for stress urinary incontinence
This study compares two different exercise programs for women with stress urinary incontinence. One program focuses on movement coordination, and the other focuses on pelvic floor muscle training. The goal is to find which approach works better.
IzmirAges 18–65 - NCT07076992Recruiting
Neonatal circumcision study in Egypt
This study looks at the challenges of circumcising newborn baby boys in Egypt. It helps researchers understand how to safely perform the procedure on infants under 3 months old.
Tanta, El-GharbiaAges Up to 3 months
Common questions
- How many kidney & urinary clinical trials are recruiting?
- Clin2 is tracking 4,386 recruiting nephrology & urology studies from the U.S. registry right now, out of 6,845 we cover in this area in total.
- What does “Kidney & urinary” cover here?
- Kidney disease and conditions of the bladder and urinary tract. We group each study into kidney & urinary based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a kidney & urinary trial near me?
- Use the search to filter kidney & urinary studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.